TP53 and neoplasm: IFN-β triggers DNA signaling pathways by inducing chemical modification of p53, ROS that affects the transcriptional activity and function of P53, all of which interfere with the tumor inhibition pathways controlled by p53 that also trigger cellular aging and senescence (Moiseeva et al., 2006).